Company: MYGN
Filing Date: 2025-08-06
Form Type: 10-Q
Source: 0000899923-25-000086
Chunk: 14

Company: MYRIAD GENETICS INC
Filing Date: 2025-08-06
Form: 10-Q
Item: Part I, Item 1
Chunk 14
---
 common stock under stock-based compensation plans, net of shares exchanged for withholding tax— (5.8)— — (5.8)Stock-based compensation expense— 9.5 — — 9.5 Net loss— — — (0.1)(0.1)Other comprehensive income, net of tax— — 0.2 — 0.2 BALANCES AT MARCH 31, 2025$0.9 $1,461.5 $(0.6)$(756.9)$704.9 Issuance of common stock under stock-based compensation plans, net of shares exchanged for withholding tax— 2.5 — — 2.5 Stock-based compensation expense— 10.7 — — 10.7 Net loss— — — (330.5)(330.5)Other comprehensive income, net of tax— — 0.5 — 0.5 BALANCES AT JUNE 30, 2025$0.9 $1,474.7 $(0.1)$(1,087.4)$388.1 

See accompanying notes to Condensed Consolidated Financial Statements.

7

MYRIAD GENETICS, INC.

AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows (unaudited)

(in millions)Six months ended June 30,20252024CASH FLOWS FROM OPERATING ACTIVITIES:Net loss$(330.6)$(62.7)Adjustments to reconcile net loss to net cash used in operating activities:Depreciation and amortization28.5 30.8 Non-cash lease expense5.6 4.4 Stock-based compensation expense20.2 26.5 Deferred income taxes— (1.6)Unrecognized tax benefits(31.5)0.9 Impairment of goodwill and long-lived assets316.7 12.8 Gain on termination of lease— (3.1)Gain on acquisition— (2.2)Other non-cash adjustments0.3 1.1 Changes in assets and liabilities:Prepaid expenses and other current assets0.3 (2.1)Trade accounts receivable(15.4)(4.5)Inventory(1.2)(4.9)Prepaid taxes2.1